24 related articles for article (PubMed ID: 30996688)
1. Retraction Note: Systematisation of biological protectors for managing the metabolic syndrome development.
Benberin VV; Sibagatova AS; Nagimtayeva AA; Akhmetova KM; Voshchenkova TA
J Diabetes Metab Disord; 2023 Dec; 22(2):1819. PubMed ID: 37969916
[TBL] [Abstract][Full Text] [Related]
2. Retraction Note: Brain injury following cardiac arrest: pathophysiology for neurocritical care.
Uchino H; Ogihara Y; Fukui H; Chijiiwa M; Sekine S; Hara N; Elmér E
J Intensive Care; 2016; 4():61. PubMed ID: 27672440
[TBL] [Abstract][Full Text] [Related]
3. Retraction Note: The quantum physiology of oxygen; from electrons to the evolution of redox signaling in the human brain.
Bailey DM
Bioelectron Med; 2019; 5():7. PubMed ID: 32232220
[TBL] [Abstract][Full Text] [Related]
4. Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer.
Frontiers Editorial Office
Front Oncol; 2024; 14():1383394. PubMed ID: 38450196
[TBL] [Abstract][Full Text] [Related]
5. Retraction:
Frontiers Editorial Office
Front Chem; 2024; 12():1433677. PubMed ID: 38855064
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Novel Nomogram to Predict the Impact of the Polymorphisms of the Variants of ICAM-1 Gene on the Prognosis of Ischemic Cardiomyopathy [Retraction].
Int J Gen Med; 2023; 16():5157-5158. PubMed ID: 37954657
[TBL] [Abstract][Full Text] [Related]
7. Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways.
Wan J; Cui J; Wang L; Wu K; Hong X; Zou Y; Zhao S; Ke H
Cancer Cell Int; 2019; 19():286. PubMed ID: 31736657
[TBL] [Abstract][Full Text] [Related]
8. Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach.
Nouri Z; Fakhri S; Nouri K; Wallace CE; Farzaei MH; Bishayee A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823876
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note to: IL‑2 augments the sorafenib‑induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway.
Ding X; Sun W; Chen J
Cancer Cell Int; 2019; 19():358. PubMed ID: 31892857
[TBL] [Abstract][Full Text] [Related]
10. Retraction Note: Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.
Wang Y; Chen X; Sun Q; Zang W; Li M; Dong Z; Zhao G
Cancer Cell Int; 2019; 19():88. PubMed ID: 30996688
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of A613T and G462T variants of DNA polymerase β weakens chemotherapy sensitivity in esophageal cancer cell lines.
Wang Y; Chen X; Sun Q; Zang W; Li M; Dong Z; Zhao G
Cancer Cell Int; 2016; 16():85. PubMed ID: 27843412
[TBL] [Abstract][Full Text] [Related]
12. Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK-Mfn2 signaling pathway.
Song J; Zhao W; Lu C; Shao X
Cancer Cell Int; 2019; 19():359. PubMed ID: 31892858
[TBL] [Abstract][Full Text] [Related]
13. Retraction Note to: Mutation pattern is an influential factor on functional mutation rates in cancer.
Du C; Wu X; Li J
Cancer Cell Int; 2017; 17():67. PubMed ID: 28690427
[TBL] [Abstract][Full Text] [Related]
14. Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.
Liu G; Wu Q; Liu G; Song X; Zhang J
Cancer Cell Int; 2016; 16():40. PubMed ID: 27252596
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
